Seminar by Promega: ‘Measuring changing metabolism and viability in cancer research’
In this seminar, luminescence metabolite detection assays (e.g. glucose uptake, glucose, lactate, glutamate, NAD(P)/NAD(P)H detection) will be introduced and examples will be provided of using those assays for studying changes in metabolic pathways of cancer cells, monitoring activation of T cells or evaluating insulin sensitivity in primary adipocytes. The advantages of incorporating real time viability measurements in metabolite detection workflow will be discussed as well as multiplexing different assay chemistries for obtaining more information from the same set of samples.
Topics include:
- Bioluminescent Metabolite assays (focus)
- Real time cell viability and toxicity assays
- Cholesterol/PCSK9 targeting assays
- Speaker: dr. Jolanta Vidugiriene, group leader R&D at Promega
- When? June 12, 9:30 – 10:30
- Where? Campus UZ Gent, MRB1 (entrance 34), 2nd floor
- Abstract and biography
Please confirm your presence by mail to Pieter.Rondou@ugent.be